These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34277203)

  • 1. A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis.
    Tagliaferri AR; Narvaneni S; Azzam MH; Grist W
    Cureus; 2021 Jun; 13(6):e15581. PubMed ID: 34277203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report.
    Chaturvedi HT; Patel V; Vasava R; Chaturvedi C
    J Family Med Prim Care; 2023 Feb; 12(2):394-396. PubMed ID: 37090999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis.
    Mustafa MS; Marshal M; Ahern E; Crowley P
    Eur J Case Rep Intern Med; 2018; 5(2):000785. PubMed ID: 30756011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms.
    Phillips WD; Vincent A
    F1000Res; 2016; 5():. PubMed ID: 27408701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.
    Sonigra KJ; Sarna K; Vaghela VP; Guthua S
    Cureus; 2022 Mar; 14(3):e23251. PubMed ID: 35449619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise.
    Ali H; Pamarthy R; Ahsan N; WashmaAwan ; Sarfraz S
    Case Rep Neurol Med; 2021; 2021():1326442. PubMed ID: 34992891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
    Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
    Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis].
    Schodrowski J; Seipelt M; Adibi-Sedeh I; Eienbröker C; Tackenberg B
    Internist (Berl); 2016 Apr; 57(4):349-61. PubMed ID: 27000188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy.
    Shames Y; Errante M; Keteku NP
    J Adv Pract Oncol; 2022 Mar; 13(2):151-157. PubMed ID: 35369395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology.
    Hehir MK; Silvestri NJ
    Neurol Clin; 2018 May; 36(2):253-260. PubMed ID: 29655448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection.
    Chatterjee T; Senthil Kumaran S; Roy M
    Cureus; 2022 Dec; 14(12):e33048. PubMed ID: 36721575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: What does a pharmacist need to know?
    Marriott M; Schwery A; VandenBerg A
    Am J Health Syst Pharm; 2023 Feb; 80(5):249-257. PubMed ID: 36373673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, respiratory function, and respiratory tract disease.
    Gilhus NE
    J Neurol; 2023 Jul; 270(7):3329-3340. PubMed ID: 37101094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Myasthenia Crisis: A Critical Emergency Department Differential.
    Hogan C; Lee J; Sleigh BC; Banerjee PR; Ganti L
    Cureus; 2020 Aug; 12(8):e9760. PubMed ID: 32944474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
    Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
    Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.